LAZARD ASSET MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$13,885,000
-29.1%
11,500,000
-29.5%
0.02%
-27.3%
Q2 2021$19,572,000
+19.1%
16,318,000
+12.5%
0.02%
+10.0%
Q1 2021$16,439,000
+46.0%
14,500,000
+45.0%
0.02%
+42.9%
Q4 2020$11,259,000
-23.0%
10,000,000
-33.3%
0.01%
-33.3%
Q3 2020$14,618,00015,000,0000.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAMDEN ASSET MANAGEMENT L P /CA 40,225,000$40,854,0001.37%
Wellesley Asset Management 15,287$15,583,0001.10%
SSI INVESTMENT MANAGEMENT LLC 4,671,000$4,738,0000.32%
WOLVERINE ASSET MANAGEMENT LLC 21,495,000$21,916,0000.24%
SHENKMAN CAPITAL MANAGEMENT INC 3,206,000$3,255,0000.18%
CAPSTONE INVESTMENT ADVISORS, LLC 22,674,000$23,142,0000.14%
AQR Arbitrage LLC 4,100,000$4,185,0000.09%
Polar Asset Management Partners Inc. 7,000,000$7,164,0000.09%
Calamos Advisors LLC 9,500,000$9,722,0000.04%
PUTNAM INVESTMENTS LLC 7,105,000$7,216,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders